103 related articles for article (PubMed ID: 9413106)
1. Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice.
Staropoli I; Frenkiel MP; Mégret F; Deubel V
Vaccine; 1997 Dec; 15(17-18):1946-54. PubMed ID: 9413106
[TBL] [Abstract][Full Text] [Related]
2. Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge.
Putnak R; Feighny R; Burrous J; Cochran M; Hackett C; Smith G; Hoke C
Am J Trop Med Hyg; 1991 Aug; 45(2):159-67. PubMed ID: 1877710
[TBL] [Abstract][Full Text] [Related]
3. Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells.
Delenda C; Frenkiel MP; Deubel V
Arch Virol; 1994; 139(1-2):197-207. PubMed ID: 7826210
[TBL] [Abstract][Full Text] [Related]
4. Analysis of C-terminally truncated dengue 2 and dengue 3 virus envelope glycoproteins: processing in insect cells and immunogenic properties in mice.
Delenda C; Staropoli I; Frenkiel MP; Cabanié L; Deubel V
J Gen Virol; 1994 Jul; 75 ( Pt 7)():1569-78. PubMed ID: 8021588
[TBL] [Abstract][Full Text] [Related]
5. Immune protection conferred by the baculovirus-related glycoprotein of Thogoto virus (Orthomyxoviridae).
Jones LD; Morse MA; Marriott AC; Nuttall PA
Virology; 1995 Oct; 213(1):249-53. PubMed ID: 7483270
[TBL] [Abstract][Full Text] [Related]
6. A recombinant envelope protein from Dengue virus purified by IMAC is bioequivalent with its immune-affinity chromatography purified counterpart.
Hermida L; Rodríguez R; Lazo L; López C; Márquez G; Páez R; Suárez C; Espinosa R; García J; Guzmán G; Guillén G
J Biotechnol; 2002 Mar; 94(2):213-6. PubMed ID: 11796173
[TBL] [Abstract][Full Text] [Related]
7. Induction of protective immunity against Dengue virus type 2: comparison of candidate live attenuated and recombinant vaccines.
Velzing J; Groen J; Drouet MT; van Amerongen G; Copra C; Osterhaus AD; Deubel V
Vaccine; 1999 Mar; 17(11-12):1312-20. PubMed ID: 10195766
[TBL] [Abstract][Full Text] [Related]
8. Carboxy-terminally truncated Dengue 4 virus envelope glycoprotein expressed in Pichia pastoris induced neutralizing antibodies and resistance to Dengue 4 virus challenge in mice.
Muné M; Rodríguez R; Ramírez R; Soto Y; Sierra B; Rodríguez Roche R; Marquez G; Garcia J; Guillén G; Guzmán MG
Arch Virol; 2003 Nov; 148(11):2267-73. PubMed ID: 14579183
[TBL] [Abstract][Full Text] [Related]
9. High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice.
Zhang ZS; Yan YS; Weng YW; Huang HL; Li SQ; He S; Zhang JM
J Virol Methods; 2007 Aug; 143(2):125-31. PubMed ID: 17532481
[TBL] [Abstract][Full Text] [Related]
10. Immunization of monkeys with baculovirus-dengue type-4 recombinants containing envelope and nonstructural proteins: evidence of priming and partial protection.
Eckels KH; Dubois DR; Summers PL; Schlesinger JJ; Shelly M; Cohen S; Zhang YM; Lai CJ; Kurane I; Rothman A
Am J Trop Med Hyg; 1994 Apr; 50(4):472-8. PubMed ID: 8166355
[TBL] [Abstract][Full Text] [Related]
11. Murine immunoglobulin G subclass responses following immunization with live dengue virus or a recombinant dengue envelope protein.
Smucny JJ; Kelly EP; Macarthy PO; King AD
Am J Trop Med Hyg; 1995 Oct; 53(4):432-7. PubMed ID: 7485699
[TBL] [Abstract][Full Text] [Related]
12. Eliciting cross-neutralizing antibodies in mice challenged with a dengue virus envelope domain III expressed in Escherichia coli.
Yang J; Zhang J; Chen W; Hu Z; Zhu J; Fang X; Yuan W; Li M; Hu X; Tan Y; Hu F; Rao X
Can J Microbiol; 2012 Apr; 58(4):369-80. PubMed ID: 22420529
[TBL] [Abstract][Full Text] [Related]
13. Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice.
Kelly EP; Greene JJ; King AD; Innis BL
Vaccine; 2000 May; 18(23):2549-59. PubMed ID: 10775789
[TBL] [Abstract][Full Text] [Related]
14. Dengue virus envelope glycoprotein can be secreted from insect cells as a fusion with the maltose-binding protein.
Staropoli I; Clément JM; Frenkiel MP; Hofnung M; Deubel V
J Virol Methods; 1996 Feb; 56(2):179-89. PubMed ID: 8882648
[TBL] [Abstract][Full Text] [Related]
15. Baculovirus surface display of sigmaC and sigmaB proteins of avian reovirus and immunogenicity of the displayed proteins in a mouse model.
Lin YH; Lee LH; Shih WL; Hu YC; Liu HJ
Vaccine; 2008 Nov; 26(50):6361-7. PubMed ID: 18809448
[TBL] [Abstract][Full Text] [Related]
16. Purification of native dengue-2 viral proteins and the ability of purified proteins to protect mice.
Feighny R; Burrous J; McCown J; Hoke C; Putnak R
Am J Trop Med Hyg; 1992 Oct; 47(4):405-12. PubMed ID: 1443338
[TBL] [Abstract][Full Text] [Related]
17. An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes.
Etemad B; Batra G; Raut R; Dahiya S; Khanam S; Swaminathan S; Khanna N
Am J Trop Med Hyg; 2008 Sep; 79(3):353-63. PubMed ID: 18784226
[TBL] [Abstract][Full Text] [Related]
18. Protection of mice from lethal infection with Aujeszky's disease virus by immunization with purified gVI.
Ishii H; Kobayashi Y; Kuroki M; Kodama Y
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1411-4. PubMed ID: 2838579
[TBL] [Abstract][Full Text] [Related]
19. Baculovirus-expressed herpes simplex virus type 2 glycoprotein D is immunogenic and protective against lethal HSV challenge.
Landolfi V; Zarley CD; Abramovitz AS; Figueroa N; Wu SL; Blasiak M; Ishizaka ST; Mishkin EM
Vaccine; 1993; 11(4):407-14. PubMed ID: 8385842
[TBL] [Abstract][Full Text] [Related]
20. A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells.
Bonafé N; Rininger JA; Chubet RG; Foellmer HG; Fader S; Anderson JF; Bushmich SL; Anthony K; Ledizet M; Fikrig E; Koski RA; Kaplan P
Vaccine; 2009 Jan; 27(2):213-22. PubMed ID: 18996430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
